ClinicalTrials.gov
public full text
Public Domain
Efficacy of Bevacizumab Monotherapy in Treatment of Metastatic Melanoma
To determine the efficacy as measured by objective tumor response of first-line treatment of metastatic melanoma with bevacizumab monotherapy
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Nivolumab +/- Ipilimumab Immunomonitoring in Metastatic Melanoma#1114118
- PD-1 and TIGIT coexpression enables selective enrichment of clonally expanded tumor-reactive CD8 T cells for melanoma TIL therapy#347883
- Proof of Concept Study With an Endothelin Receptor B Inhibitor (BQ-788) for Human Melanoma#1212998
- Elucidating the role of medicinal plants in melanoma treatment : a review on metastatic progression and phytochemical intervention#1360882
- Loss of LYN Is Frequent in Targeted Therapy–Resistant Melanoma Cells and Favors Metastatic Properties#28871
Record · ID 1281537
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive